Inhibikase Therapeutics I... (IKT)
undefined
undefined%
At close: undefined
3.22
1.90%
After-hours Jan 06, 2025, 04:53 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -19.03M -18.05M -14.79M -2.85M -5.72M -2.15M -436.07K -628.74K
Depreciation & Amortization 177.40K 6.72K n/a n/a n/a n/a n/a n/a
Stock-Based Compensation 500.15K 458.15K 1.53M 573.70K 1.44M 642.23K 300.66K 310.09K
Other Working Capital 699.28K 39.53K -2.33M -217.57K 1.17M 256.73K 159.41K 98.91K
Other Non-Cash Items 31.54K 67.00K 721.63K 1.61M 2.32M 709.27K 534.62K 95.71K
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 234.76K 171.18K -1.76M -464.64K 1.63M 1.52M -32.76K 193.36K
Operating Cash Flow -18.09M -17.35M -14.30M -1.13M -338.29K 714.99K -126.39K -29.57K
Capital Expenditures -14.24K -243.25K n/a n/a n/a n/a n/a n/a
Acquisitions n/a 243.25K n/a n/a n/a n/a n/a n/a
Purchase of Investments -29.43M -20.73M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 41.10M 4.96M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -243.25K n/a n/a n/a 87.10K n/a n/a
Investing Cash Flow 11.66M -16.01M n/a n/a n/a 87.10K n/a n/a
Debt Repayment n/a -248.91K -42.53K 272.80K -22.81K -26.31K n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -138.56K n/a 848.00 n/a n/a -1.59M 131.02K -23.77K
Financial Cash Flow 8.41M -204.77K 41.09M 15.06M -22.81K -439.19K 131.02K -23.77K
Net Cash Flow 1.98M -33.56M 26.80M 13.94M -361.10K 362.89K 4.63K -53.34K
Free Cash Flow -18.10M -17.59M -14.30M -1.13M -338.29K 714.99K -126.39K -29.57K

Create Price Alert on IKT

Your price alert will notify you when the stock price is above 3.16.

Add to Watchlist